PCK Reporter

March 1, 2013

The Government Has Tabled Bill C-56, Combating Counterfeit Products Act

Today Ministers of Industry and Public Safety tabled Bill C-56, Combating Counterfeit Products Act. According to its summary, Bill C-56 amends the Copyright Act and the […]
February 27, 2013

Teva and Apotex’s Allegations, that the GLEEVEC Patent Is Invalid, Are Not Justified

Novartis Pharmaceuticals Canada Inc. v. Apotex Inc., 2013 FC 142 Novartis is the owner of Canadian Patent No. 2,093,203 (the '203 Patent) covering imatinib mesylate, the […]
February 27, 2013

Ont. Div. Ct. Reinforces Unavailability of Equitable Disgorgement under S. 8 of PM(NOC) Regs

Apotex Inc. v. Eli Lilly, 2013 ONSC 1135 (Div. Ct.) Lilly sought leave to appeal from a decision of Justice J. Macdonald of the Ontario Superior […]
February 25, 2013

FCA Upholds Order that Apotex Produce Escitalopram Samples

Apotex Inc. v. H. Lundbeck A/S, 2013 FCA 46 Apotex appealed from the FC order upholding the order of Prothonotary Tabib, who ordered Apotex to provide […]
February 25, 2013

FCA Upholds Order that Apotex Produce Esomeprazole Samples in Patent Infringement Case

Apotex Inc. v. Astrazeneca Canada Inc., 2013 FCA 47 Apotex is the defendant to an infringement action brought by AstraZeneca. In the course of that proceeding, […]
February 25, 2013

FCA Clarifies Test for Production of Samples under Rule 249 of the Federal Court Rules

Apotex Inc. v. Eli Lilly Canada Inc., 2013 FCA 45 This was an appeal by Apotex from a FC decision upholding the order of Prothonotary Aronovitch […]
February 21, 2013

Divided FCA Denies Data Protection for THALOMID

Canada (Health) v. Celgene Inc., 2013 FCA 43 This was an appeal from a Federal Court decision granting Celgene’s application for judicial review and quashing the […]
February 21, 2013

ONSC Refuses to Strike Apotex’s Claim that It Has Lost Some of its S. 8 Claims Against the Brands Because the Minister of Health Improperly Delayed Issuing its NOCs

Apotex Inc. v. Canada, 2013 ONSC 986 This motion was brought pursuant to rule 21.01(1)(b) and (3)(d) and rules 25.06(1) and 25.11 of the Rules of […]
February 11, 2013

PM(NOC): Notice of Allegation Against the LYRICA Patent Upheld on Grounds of Insufficiency and Inutility for Lack of Sound Prediction

Pfizer Canada et al. v. Pharmascience Inc., 2013 FC 120 Pfizer brought an application under the PM(NOC) Regulations to prohibit the Minister of Health from issuing […]
February 7, 2013

Two Great Ways to Contact Us

1300 Yonge Street, Suite 500 Toronto Canada, M4T 1X3 T: 416.920.8170 F: 416.920.1350